Rolls-Royce invests in Oxford spin-out

Oxford BioSignals Ltd, one of the University's spin-out companies, has announced that Rolls-Royce has made a strategic equity investment in the company. The partnership between Oxford BioSignals, a leader in the intelligent signal processing field, and the international aerospace company will provide a comprehensive foundation for Oxford Biosignals to achieve its goals.

In addition to a cash contribution of £3.2m, Rolls-Royce is making a commitment to significant future business with Oxford BioSignals, who will provide intelligent signalling processing products and solutions for engine condition monitoring technology.

Dr Chris Floyd, Business Development Director for Rolls-Royce, said: 'The technology provided by Oxford BioSignals enables us to analyse output from multiple sensors on an aircraft engine in an integrated way, rather than relying on several different instruments. This will allow us to detect trends in engine performance more effectively. Our investment in Oxford BioSignals also gives us an opportunity to capitalise on the value of this technology to other markets. All in all this is a very exciting development for the company.'

Oxford BioSignals has been developing and supplying innovative diagnostic monitoring solutions to the healthcare market since it was founded in May 2000. Over the last two years, it has expanded its activities to supply jet engine condition monitoring products to the Rolls-Royce aero engine business in the UK, Europe, US and Far East.

www.ox.ac.uk/media


Oxford BioSignals Ltd

www.oxford-biosignals.com

Oxford Biosignals technology provides intelligent data acquisition and advanced signal interpretation for complex signal monitoring across the Medical and Industrial sectors.

The generic technology is based on neural networks and intelligent algorithms and covers a range of applications including innovative sleep diagnostics systems, patient health monitoring software and Industrial applications spanning aero engines, railways, pipelines and energy.

The technology enables unique signal interpretation facilitating reduced costs, decision support and integrity monitoring. Specialist expertise includes high volume, real time, data acquisition techniques and system prognosis.

http://www.isis-innovation.com/spinout/oxbiosignals.html